Fidelis Capital Partners LLC Buys 5,923 Shares of Cardinal Health, Inc. $CAH

Fidelis Capital Partners LLC raised its stake in Cardinal Health, Inc. (NYSE:CAH) by 296.0% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 7,924 shares of the company’s stock after buying an additional 5,923 shares during the period. Fidelis Capital Partners LLC’s holdings in Cardinal Health were worth $1,244,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Baird Financial Group Inc. lifted its stake in Cardinal Health by 107.2% in the second quarter. Baird Financial Group Inc. now owns 99,393 shares of the company’s stock worth $16,698,000 after acquiring an additional 51,416 shares during the period. Voya Investment Management LLC raised its holdings in shares of Cardinal Health by 298.3% in the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after purchasing an additional 615,398 shares in the last quarter. Nomura Holdings Inc. lifted its position in shares of Cardinal Health by 568.0% in the 2nd quarter. Nomura Holdings Inc. now owns 85,293 shares of the company’s stock worth $14,329,000 after purchasing an additional 72,525 shares during the period. Marshall Wace LLP lifted its position in shares of Cardinal Health by 19.1% in the 2nd quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock worth $324,402,000 after purchasing an additional 309,335 shares during the period. Finally, Columbus Macro LLC boosted its stake in shares of Cardinal Health by 102.8% during the third quarter. Columbus Macro LLC now owns 36,529 shares of the company’s stock valued at $5,734,000 after purchasing an additional 18,516 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal hit an all-time high, reinforcing upside momentum and drawing more attention from momentum and trend-following buyers. Cardinal Health stock hits all-time high at $215.54
• Positive Sentiment: Morgan Stanley upgraded competitor Cencora, calling a “golden era” for drug distributors — a sector-level endorsement that likely lifts sentiment for Cardinal as a leading distributor. Cencora upgraded as Morgan Stanley cites a “golden era” for drug distributors
• Positive Sentiment: Multiple brokers and analysts are highlighting CAH as a top pick for Q4/early 2026, citing solid earnings trends and cooled inflation — this increases the likelihood of continued analyst revisions and inflows. 5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
• Positive Sentiment: Zacks expects CAH to report growing earnings next week and notes the company has the characteristics of a likely earnings beat — a near-term catalyst that can push the stock higher if results confirm expectations. Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release
• Positive Sentiment: High-profile bullish commentary (e.g., Jim Cramer saying he can see CAH reaching $300) can attract retail flows and increase trading momentum. Jim Cramer on Cardinal Health: “I Can See That Stock Going to $300”
• Positive Sentiment: IBD highlights raised 2026 guidance and strong momentum, reinforcing the narrative that growth and execution are improving — supports higher valuations. IBD Stock Of The Day: Why Cardinal Health’s Momentum Is ‘Special’ — And Not Over Yet
• Positive Sentiment: Short interest fell ~15.9% in January, lowering potential downside pressure from short-covering dynamics and removing a near-term bearish crowd — fewer shorts can mean steadier rallies. (data summary)
• Neutral Sentiment: Zacks published a valuation-focused piece asking whether CAH is undervalued — useful for longer-term investors but less of an immediate price catalyst. Is Cardinal Health (CAH) Stock Undervalued Right Now?
• Neutral Sentiment: Routine earnings calendar note: Cardinal is expected to announce quarterly results Thursday — the report itself is the key near-term event that could change the stock’s direction. Cardinal Health (CAH) Expected to Announce Quarterly Earnings on Thursday

Analyst Ratings Changes

CAH has been the subject of a number of recent research reports. TD Cowen reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $190.00 to $244.00 in a research report on Friday, January 9th. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Mizuho set a $222.00 target price on Cardinal Health in a research note on Monday, January 12th. Finally, Robert W. Baird set a $250.00 target price on shares of Cardinal Health in a report on Wednesday, January 14th. Fourteen analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $224.73.

Cardinal Health Stock Up 0.3%

Shares of Cardinal Health stock opened at $211.02 on Friday. The company has a 50 day moving average price of $206.13 and a 200 day moving average price of $177.53. The firm has a market capitalization of $50.14 billion, a P/E ratio of 31.83, a PEG ratio of 1.43 and a beta of 0.65. Cardinal Health, Inc. has a 52 week low of $120.72 and a 52 week high of $216.51.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. Cardinal Health’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.88 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were paid a $0.5107 dividend. The ex-dividend date was Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is 30.77%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.